Showing results (161-170 of 300) with videos related to

Sort By:
Pageof 30
Clinical Colorectal Cancer|June 7, 2024
VIC Regimen (Vemurafenib/Irinotecan/Cetuximab) Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Unresectable or Metastatic Colorectal Cancer in Asian Patients: A Prospective Cohort StudyYijiao Chen, Dexiang Zhu, Yiyi Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2022
Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric CancerKe Peng, Feifei Zhang, Yichen Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2017
HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaManish A Shah, Rui-Hua Xu, Yung-Jue Bang, et al.
Journal of Cellular Physiology|February 13, 2020
A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancerKe Peng, Erbao Chen, Wei Li, et al.
Cell Death & Disease|September 22, 2022
Ca<sub>v</sub>2.2-NFAT2-USP43 axis promotes invadopodia formation and breast cancer metastasis through cortactin stabilizationYing Xue, Min Li, Jie Hu, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|October 12, 2018
An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer PatientsLi Liang, Jiawen Tian, Yiyi Yu, et al.
Cancer Communications (London, England)|June 26, 2019
Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trialTianshu Liu, Yanru Qin, Jin Li, et al.
Frontiers in Oncology|April 3, 2023
Getting Recovery Right After Neck Dissection (GRRAND-F): Mixed-methods feasibility study to design a pragmatic randomised controlled trialToby O Smith, Angela Garrett, Tianshu Liu, et al.
Oncotarget|April 22, 2017
Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signalingYina Wang, Haiyan Ma, Chongqiang Zhao, et al.
Oncotarget|April 8, 2017
Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal typeChen Xu, Yalan Liu, Dongxian Jiang, et al.
Pageof 30